Navigation Links
Pharma Opinions Site Reviews the Breakthrough Drugs of Pharmaceutical Companies
Date:10/21/2008

Quick glance at the latest new drugs. Pharma Opinions unveils a new site were top notch biotech companies will see their new approved products reviewed and commented.

Costa de Caparica, Portugal (PRWEB) October 21, 2008 -- A new blog review on the most recent approved drugs mainly in the U.S. Pharma Opinions unveils a new site were top notch biotech companies will see their new, approved products reviewed and commented on.

Breakthrough drugs and pharmaceutical companies are reviewed each time an approval is issued by FDA. The site extracts all the 'juicy' information from the companies Press Releases and puts it 'plain and simple' for the general opinion to understand the 'facts and figures' of the reason for the drug to be approved, and why it is such a breakthrough.

There will be also interviews with CEOs and officers of the pharmaceutical companies.

Among the most recent reviewed companies are Generex, Biovail and Cephalon

The blog is owned by Bruno Miguel Espalha, a portuguese 27 year old Pharmacist.

You can find the site at pharmaopinions.blogspot.com.

###

Read the full story at http://www.prweb.com/releases/pharmaceuticalblog/newdrugs/prweb1420944.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the BIOCOM Investor Conference
2. Amylin Pharmaceuticals Reports Third Quarter Financial Results
3. New Pharmaceutical Company to Target Alzheimers Disease
4. Acasti Pharma completes offer to exchange outstanding Neptune Technologies dividend notes
5. Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer
6. China Pharma Holdings, Inc. Appoints The Ruth Group
7. Simcere Pharmaceutical Group to Announce Third Quarter 2008 Earnings on Thursday, November 6, 2008
8. Anadys Pharmaceuticals to Present at BIOCOM Investor Conference 2008
9. Bio-Pharma Industry Improves Patient Outcomes Through Continuing Medical Education (CME)
10. Peregrine Pharmaceuticals Completes Patient Enrollment In First Stage of Bavituximab Phase II Lung Cancer Trial
11. Rib-X Pharmaceuticals to Present at the 2008 ICAAC/IDSA Joint Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2017)... ... May 19, 2017 , ... ... educational conference of the American Association of Bioanalysts (AAB) and the College of ... Houston. The conference reinforces AAB’s commitment to excellence in clinical laboratory services and ...
(Date:5/18/2017)... ... May 18, 2017 , ... Dr. Ralph ... at the Prince Of Wales Private Hospital. The procedure was performed on a ... patient failed conservative treatments prior to undergoing surgery. , The AxioMed viscoelastic disc ...
(Date:5/18/2017)... ... May 17, 2017 , ... ... enhances its scientific power by providing investigators access to a high-profile scientific ... join the scientific advisory board. “We are committed to offering superior services ...
(Date:5/18/2017)... Station, TX (PRWEB) , ... May 17, 2017 ... ... design and construction, announced today that their Chief Executive Officer, Maik Jornitz, was ... List. The UK publication’s Power List celebrates 100 individuals “involved in bettering the ...
Breaking Biology Technology:
(Date:3/28/2017)... 28, 2017 The report "Video ... Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), and ... Global Forecast to 2022", published by MarketsandMarkets, the market ... is projected to reach USD 75.64 Billion by 2022, ... The base year considered for the study is 2016 ...
(Date:3/24/2017)... The Controller General of Immigration from Maldives Mr. Mohamed Anwar ... prestigious international IAIR Award for the most innovative high security ePassport and ... ... Maldives Immigration Controller General, Mr. Mohamed ... the right) have received the IAIR award for the "Most innovative high ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based and Touchless), ... published by MarketsandMarkets, the market is expected to be worth USD 18.98 billion ... Continue Reading ... ...      (Logo: ...
Breaking Biology News(10 mins):